Evidence map›Paper›PMID 32058723›Full record

ArticleJournal of proteome research2020

Comprehensive Detection of Single Amino Acid Variants and Evaluation of Their Deleterious Potential in a PANC-1 Cell Line.

Zhijing Tan, Jianhui Zhu, Paul M Stemmer, Liangliang Sun, Zhichang Yang, Kendall Schultz, Matthew J Gaffrey, Anthony J Cesnik, Xinpei Yi, Xiaohu Hao and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Zhijing TanDepartment of Surgery, The University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0003-3618-5388
Jianhui ZhuDepartment of Surgery, The University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-0051-7777
Paul M StemmerInstitute of Environmental Health Sciences, Wayne State University, Detroit, Michigan 48202, United States.ORCID 0000-0003-3315-9846
Liangliang SunDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, Michigan 48824, United States.ORCID 0000-0001-8939-5042
Zhichang YangDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, Michigan 48824, United States.
Kendall SchultzIntegrative Omics Group, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Matthew J GaffreyIntegrative Omics Group, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Anthony J CesnikDepartment of Genetics, Stanford University, Stanford, California 94305, United States.
Xinpei YiLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas 77030, United States.
Xiaohu HaoShanghai Institutes for Biological Science, Chinese Academy of Science, Shanghai 200031, China.
Michael R ShortreedDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
Tujin ShiIntegrative Omics Group, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.ORCID 0000-0002-5592-3588
David M LubmanDepartment of Surgery, The University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0001-7731-0232
Pacific Northwest National Laboratory · USUniversity of Michigan · USMichigan State University · USBaylor College of Medicine · USShanghai Institutes for Biological Sciences · CNStanford University · USUniversity of Wisconsin–Madison · USWayne State University · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
Research Training for Computation and Informatics in Biology and MedicineT15LM007359 · NLM · UNIVERSITY OF WISCONSIN-MADISON · PI Mark W. Craven, Colin Noel Dewey · 2002 to 2026
$22.6M
Pilot Project ProgramP30ES020957 · NIEHS · WAYNE STATE UNIVERSITY · PI RUNGE-MORRIS, MELISSA A · 2014 to 2021
$10.1M
Supplemental for Detection of Glycopeptides of MCI in Patient SerumR01CA160254 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David M. Lubman · 2012 to 2026
$5.4M
Microsequencing in an Ion Trap/reTOF DeviceR01GM049500 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUBMAN, DAVID M. · 1994 to 2016
$3.0M
Quantitative proteomics of Zebrafish embryos and blastomeresR01GM125991 · NIGMS · MICHIGAN STATE UNIVERSITY · PI SUN, LIANGLIANG · 2018 to 2022
$1.7M
An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cellsR21CA223715 · NCI · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SHI, TUJIN · 2018 to 2020
$691k
Novel NeuCode Tagging Reagents for Identification and Quantification of Intact Proteoforms in Cancer TissuesR21CA223887 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SMITH, LLOYD M · 2018 to 2020
$666k
Orbitrap Velos with ETD for Wayne State ProteomicsS10OD010700 · OD · WAYNE STATE UNIVERSITY · PI STEMMER, PAUL M · 2012 to 2012
$575k
NCI NIH HHS P30 CA022453NCI NIH HHS R01 CA160254NCI NIH HHS R21 CA223715NCI NIH HHS R21 CA223887NIEHS NIH HHS P30 ES020957NIGMS NIH HHS R01 GM049500NIGMS NIH HHS R01 GM125991NIH HHS S10 OD010700NLM NIH HHS T15 LM007359
6 · The paper itself

Abstract

Identifying single amino acid variants (SAAVs) in cancer is critical for precision oncology. Several advanced algorithms are now available to identify SAAVs, but attempts to combine different algorithms and optimize them on large data sets to achieve a more comprehensive coverage of SAAVs have not been implemented. Herein, we report an expanded detection of SAAVs in the PANC-1 cell line using three different strategies, which results in the identification of 540 SAAVs in the mass spectrometry data. Among the set of 540 SAAVs, 79 are evaluated as deleterious SAAVs based on analysis using the novel AssVar software in which one of the driver mutations found in each protein of KRAS, TP53, and SLC37A4 is further validated using independent selected reaction monitoring (SRM) analysis. Our study represents the most comprehensive discovery of SAAVs to date and the first large-scale detection of deleterious SAAVs in the PANC-1 cell line. This work may serve as the basis for future research in pancreatic cancer and personal immunotherapy and treatment.

Indexed as

Amino AcidsPancreatic NeoplasmsAntiportersCell LineHumansMonosaccharide Transport ProteinsPrecision MedicineProteinsAmino AcidsAntiportersMonosaccharide Transport ProteinsProteinsSLC37A4 protein, humandeleterious mutationLC-MS/MSLC-SRMPANC-1 cell line, KRAS, TP53PRISM-SRMsingle amino acid variant

Identifiers

PMID32058723
PMCPMC7162681
OpenAlexW3006633693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.